G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 120 filers reported holding G1 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 58.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $69 | -21.6% | 25,820 | +58.5% | 0.01% | -33.3% |
| Q4 2022 | $88 | -100.0% | 16,291 | +9.3% | 0.01% | -50.0% |
| Q3 2022 | $186,000 | +1.1% | 14,901 | -38.4% | 0.02% | -18.2% |
| Q1 2022 | $184,000 | -23.3% | 24,187 | +81.6% | 0.02% | -43.6% |
| Q4 2020 | $240,000 | +3.4% | 13,319 | -33.7% | 0.04% | +5.4% |
| Q3 2020 | $232,000 | +5.9% | 20,085 | +122.9% | 0.04% | +12.1% |
| Q2 2020 | $219,000 | -2.2% | 9,010 | -33.2% | 0.03% | -10.8% |
| Q1 2019 | $224,000 | -18.2% | 13,488 | +157.9% | 0.04% | -2.6% |
| Q3 2018 | $274,000 | – | 5,230 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |